Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(Q2)Jun 30, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | (Q3)Sep 30, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 45.52%2.56M | 15.34%2.29M | 15.34%2.29M | 418.07%2.64M | --1.76M | --2.34M | -18.20%1.98M | --1.98M | -82.10%509K | -13.62%2.42M |
-Cash and cash equivalents | 50.32%2.37M | 18.83%2.08M | 18.83%2.08M | 827.86%2.43M | --1.58M | --2.16M | -18.33%1.75M | --1.75M | -89.77%262K | -16.51%2.14M |
-Short-term investments | 4.84%195K | -10.64%210K | -10.64%210K | -16.60%206K | --186K | --178K | -17.25%235K | --235K | -12.10%247K | 16.87%284K |
Receivables | -21.96%2.65M | -14.67%2.79M | -14.67%2.79M | -12.48%3.14M | --3.4M | --2.9M | 72.90%3.27M | --3.27M | 51.52%3.59M | -36.50%1.89M |
-Accounts receivable | -21.10%2.65M | -14.98%2.78M | -14.98%2.78M | -13.94%3.08M | --3.36M | --2.9M | 72.61%3.26M | --3.26M | 51.97%3.58M | -36.56%1.89M |
-Taxes receivable | --0 | 100.00%18K | 100.00%18K | 425.00%63K | --37K | --0 | 350.00%9K | --9K | -20.00%12K | --2K |
Inventory | -9.00%9.95M | -6.47%10M | -6.47%10M | -7.41%10.45M | --10.94M | --10.91M | -3.56%10.69M | --10.69M | 2.01%11.29M | -6.05%11.09M |
Other current assets | -29.94%117K | -20.85%205K | -20.85%205K | -4.91%252K | --167K | --150K | 17.73%259K | --259K | 1.53%265K | -16.67%220K |
Total current assets | -6.01%15.29M | -5.69%15.29M | -5.69%15.29M | 5.31%16.48M | --16.26M | --16.3M | 3.73%16.21M | --16.21M | -5.36%15.65M | -12.48%15.63M |
Non current assets | ||||||||||
Net PPE | -32.01%223K | -33.82%270K | -33.82%270K | -39.02%286K | --328K | --361K | -36.35%408K | --408K | -32.03%469K | -34.26%641K |
-Gross PPE | ---- | 1.27%3.75M | 1.27%3.75M | ---- | ---- | ---- | 1.09%3.7M | --3.7M | ---- | -22.69%3.66M |
-Accumulated depreciation | ---- | -5.62%-3.48M | -5.62%-3.48M | ---- | ---- | ---- | -9.04%-3.29M | ---3.29M | ---- | 19.69%-3.02M |
Goodwill and other intangible assets | 0.00%868K | 0.00%868K | 0.00%868K | 0.00%868K | --868K | --868K | 0.00%868K | --868K | 0.00%868K | 0.00%868K |
-Goodwill | 0.00%868K | 0.00%868K | 0.00%868K | 0.00%868K | --868K | --868K | 0.00%868K | --868K | 0.00%868K | 0.00%868K |
Non current deferred assets | --300K | --300K | --300K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
Other non current assets | -17.50%33K | 0.00%40K | 0.00%40K | 0.00%40K | --40K | --40K | 0.00%40K | --40K | 0.00%40K | 14.29%40K |
Total non current assets | 15.21%1.42M | 12.31%1.48M | 12.31%1.48M | -13.29%1.19M | --1.24M | --1.27M | -15.04%1.32M | --1.32M | -13.83%1.38M | -17.52%1.55M |
Total assets | -4.51%16.71M | -4.34%16.76M | -4.34%16.76M | 3.81%17.68M | --17.5M | --17.57M | 2.04%17.52M | --17.52M | -6.11%17.03M | -12.96%17.17M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -6.75%732K | -20.56%483K | -20.56%483K | 32.61%793K | --785K | --770K | 20.87%608K | --608K | 14.34%598K | -5.98%503K |
-accounts payable | -7.39%727K | -20.56%483K | -20.56%483K | 32.61%793K | --785K | --767K | 20.87%608K | --608K | 14.34%598K | -1.37%503K |
-Total tax payable | --5K | ---- | ---- | ---- | ---- | --3K | ---- | ---- | ---- | ---- |
Current accrued expenses | 12.56%896K | 16.82%1M | 16.82%1M | 2.36%825K | --796K | --769K | -5.10%856K | --856K | -23.38%806K | -21.50%902K |
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -17.86%1.73M |
-Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -17.86%1.73M |
Current deferred liabilities | -60.26%151K | -53.97%87K | -53.97%87K | 50.46%328K | --380K | --326K | -0.53%189K | --189K | 19.13%218K | 1,017.65%190K |
Current liabilities | -9.28%1.78M | -5.02%1.57M | -5.02%1.57M | 19.98%1.95M | --1.96M | --1.87M | -50.21%1.65M | --1.65M | -54.57%1.62M | -13.47%3.32M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | ---- | ---- | ---- | -31.44%1.03M | --1.18M | --1.28M | --1.41M | --1.41M | --1.5M | ---- |
-Long term debt | ---- | ---- | ---- | -31.44%1.03M | --1.18M | --1.28M | --1.41M | --1.41M | --1.5M | ---- |
Other non current liabilities | ---- | ---- | ---- | ---- | --4K | --9K | -56.76%16K | --16K | --22K | 825.00%37K |
Total non current liabilities | --0 | --0 | --0 | -32.43%1.03M | --1.18M | --1.29M | 3,754.05%1.43M | --1.43M | 3,347.73%1.52M | 825.00%37K |
Total liabilities | -43.43%1.78M | -49.01%1.57M | -49.01%1.57M | -5.35%2.97M | --3.15M | --3.15M | -8.28%3.08M | --3.08M | -13.14%3.14M | -12.60%3.36M |
Shareholders'equity | ||||||||||
Share capital | -4.39%479K | -5.06%488K | -5.06%488K | -5.06%488K | --501K | --514K | -1.53%514K | --514K | -1.53%514K | -0.19%522K |
-common stock | -4.39%479K | -5.06%488K | -5.06%488K | -5.06%488K | --501K | --514K | -1.53%514K | --514K | -1.53%514K | -0.19%522K |
Retained earnings | 28.85%-4.49M | 21.69%-5.03M | 21.69%-5.03M | 16.38%-5.85M | ---6.31M | ---6.38M | 12.32%-6.42M | ---6.42M | -5.01%-7M | -37.62%-7.32M |
Paid-in capital | -2.78%21.74M | -2.78%22.03M | -2.78%22.03M | -2.78%22.02M | --22.36M | --22.67M | -0.83%22.66M | --22.66M | -1.13%22.65M | 0.11%22.85M |
Less: Treasury stock | 29.55%2.79M | 0.00%2.27M | 0.00%2.27M | -14.48%1.91M | --2.16M | --2.35M | 2.16%2.27M | --2.27M | 0.54%2.24M | 4.31%2.23M |
Gains losses not affecting retained earnings | 97.30%-1K | 35.14%-24K | 35.14%-24K | 3.33%-29K | ---37K | ---44K | -362.50%-37K | ---37K | -233.33%-30K | -60.00%-8K |
Total stockholders'equity | 4.01%14.93M | 5.19%15.19M | 5.19%15.19M | 5.87%14.71M | --14.36M | --14.41M | 4.55%14.45M | --14.45M | -4.36%13.89M | -13.05%13.82M |
Total equity | 4.01%14.93M | 5.19%15.19M | 5.19%15.19M | 5.87%14.71M | --14.36M | --14.41M | 4.55%14.45M | --14.45M | -4.36%13.89M | -13.05%13.82M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |